Oculis Holding AG

General ticker "OCS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.3B (TTM average)

Oculis Holding AG does not follow the US Stock Market performance with the rate: -22.0%.

Estimated limits based on current volatility of 2.6%: low 8.67$, high 9.13$

Factors to consider:

  • Total employees count: 60 (+22.4%) as of 2025
  • Current price 34.3% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [13.28$, 26.46$]
  • 2026-12-31 to 2027-12-31 estimated range: [11.18$, 23.13$]

Financial Metrics affecting the OCS estimates:

  • Negative: with PPE of -8.9 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Negative: negative Industry operating income (median)
  • Negative: 0.07 < Interest expense per share per price, % of 0.09
  • Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -28.65
  • Negative: Investing cash flow per share per price, % of -7.06 <= -4.49
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Shareholder equity ratio, % of 83.09 > 81.92

Similar symbols

Short-term OCS quotes

Long-term OCS plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue CHF0.00MM CHF0.69MM CHF0.00MM
Operating Expenses CHF80.71MM CHF73.89MM CHF79.15MM
Operating Income CHF-80.71MM CHF-73.20MM CHF-79.15MM
Non-Operating Income CHF-7.98MM CHF-12.73MM CHF-15.54MM
Interest Expense CHF1.46MM CHF0.64MM CHF0.80MM
R&D Expense CHF29.25MM CHF52.08MM CHF54.52MM
Income(Loss) CHF-88.69MM CHF-85.94MM CHF-94.69MM
Taxes CHF0.00MM CHF0.00MM CHF0.18MM
Net Income(Loss)* CHF-88.80MM CHF-85.78MM CHF-94.51MM
Stockholders Equity CHF93.73MM CHF73.38MM CHF196.29MM
Assets CHF114.35MM CHF120.35MM CHF236.23MM
Operating Cash Flow CHF-53.84MM CHF-47.50MM CHF-62.22MM
Capital expenditure CHF0.05MM CHF0.23MM CHF0.29MM
Investing Cash Flow CHF-54.21MM CHF-17.56MM CHF-59.38MM
Financing Cash Flow CHF129.67MM CHF54.03MM CHF178.60MM
Earnings Per Share** CHF-2.97 CHF-2.12 CHF-1.81

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.